Form 8-K - Current report:
SEC Accession No. 0000950144-07-006912
Filing Date
2007-07-27
Accepted
2007-07-27 12:53:20
Documents
7
Period of Report
2007-07-24
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ADVANCED VIRAL RESEARCH CORP. g08578e8vk.htm 8-K 18786
2 EX-10.1 SECURITIES PURCHASE AGREEMENT g08578exv10w1.htm EX-10.1 114993
3 EX-10.2 SERIES A CONVERTIBLE DEBENTURE g08578exv10w2.htm EX-10.2 87765
4 EX-10.3 SERIES B CONVERTIBLE DEBENTURE g08578exv10w3.htm EX-10.3 88685
5 EX-10.4 SERIES A WARRANT g08578exv10w4.htm EX-10.4 73313
6 EX-10.5 SERIES B WARRANT g08578exv10w5.htm EX-10.5 73130
7 EX-10.6 REGISTRATION RIGHTS AGREEMENT g08578exv10w6.htm EX-10.6 97946
  Complete submission text file 0000950144-07-006912.txt   556164
Mailing Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107
Business Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107 9143767383
ADVANCED VIRAL RESEARCH CORP (Filer) CIK: 0000786623 (see all company filings)

EIN.: 592646820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-18293 | Film No.: 071005699
SIC: 2834 Pharmaceutical Preparations